Apellis Pharmaceuticals
Price & Volume
Stats
See more52W Range | $16.10-$40.48 |
Market Cap | $5.1B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $1B |
Revenue Growth (YoY) | -5.9% |
Gross Profit (12 Mos) | $605.6M |
Diluted EPS | $0.18 |
News
See moreYahoo Finance • 2 days ago
Where the New Houses Are—and What That Says About Growth
Yahoo Finance • 2 days ago
Catalyst Watch: OPEC meeting, FedEx talks freight, inflation reads, and SpaceX IPO buzz
Yahoo Finance • 4 days ago
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Boeing, Datadog, Disney, Formula One Group, Nike, Rivian, Rocket Lab, ServiceNow, and More
Yahoo Finance • 4 days ago
Biogen uplifts rare disease pipeline with $5.6bn Apellis buyout
About
CEO | Dr. Cedric Francois M.D., Ph.D. |
CFO | Mr. Timothy E. Sullivan |
Address | 100 Fifth Avenue, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 733 |
